Products with Anticancer bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN2298 | 11-Keto-beta-boswellic acid |
| 11-Keto-beta-boswellic acid, a novel Nrf2 activator, and a selective 5-lipoxygenase (5-LOX) inhibitor; it exerts dose dependent cardioprotective effect manifested by dose-dependent reduction in serum lactate dehydrogenase; and it can increase the Nrf2 and HO-1 expression, which provides protection against oxygen and glucose deprivation (OGD)-induced oxidative insult. 11-Keto-beta-boswellic acid possesses significant anti-inflammatory, and anti-tumoral activities. | |
| BCN2300 | Cucurbitacin E |
| Cucurbitacin E has prevention of neurodegeneration, it has potent anti-proliferative, antineoplastic, anti-inflammatory and analgesic actions, it also exhibits immunosuppressive effect by attenuating critical cytokine expression through down-regulating the NF-κB signaling pathway. | |
| BCN2303 | 10-Methoxycamptothecin |
| 10-Methoxycamptothecin possesses high anti-cancer activity. | |
| BCN2304 | Alisol B acetate |
| Alisol B acetate can induce Bax nuclear translocation and apoptosis in human hormone-resistant prostate cancer PC-3 cells, the Bax activation and translocation from the cytosol to nucleus might be a crucial response to the apoptotic effect. Alisol B acetate exhibits an antiproliferative effect in SGC7901 cells by inducing apoptosis, apoptosis of SGC7901 cells involves mitochondria-caspase and PI3K/Akt dependent pathways. | |
| BCN2305 | Solamargine |
| Solamargine has potential anti-trypanosomal, and anti-cancer activities; interactions between the glycoalkaloids solasonine and solamargine have inhibition of fungal growth. Solamargine significantly inhibits migration and invasion of HepG2 cells by down-regulating MMP-2 and MMP-9 expression and activity. | |
